These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31855281)
1. EZH2 enhances expression of CCL5 to promote recruitment of macrophages and invasion in lung cancer. Xia L; Zhu X; Zhang L; Xu Y; Chen G; Luo J Biotechnol Appl Biochem; 2020 Nov; 67(6):1011-1019. PubMed ID: 31855281 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway. Zhang G; Wu YJ; Yan F Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9480-9488. PubMed ID: 31773700 [TBL] [Abstract][Full Text] [Related]
3. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003 [TBL] [Abstract][Full Text] [Related]
4. MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2. Hou Y; Li L; Ju Y; Lu Y; Chang L; Xiang X J Cell Biochem; 2017 Oct; 118(10):3142-3149. PubMed ID: 27966775 [TBL] [Abstract][Full Text] [Related]
5. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2. Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878 [TBL] [Abstract][Full Text] [Related]
7. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo. Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985 [TBL] [Abstract][Full Text] [Related]
8. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745 [TBL] [Abstract][Full Text] [Related]
9. [Development of New Molecular EZH2 on Lung Cancer Invasion and Metastasis]. Xia H; Yu C; Zhang W; Zhang B; Zhao Y Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):98-101. PubMed ID: 26903164 [TBL] [Abstract][Full Text] [Related]
10. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells. Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757 [TBL] [Abstract][Full Text] [Related]
11. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells. Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276 [TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression. Zhou X; Jiao D; Dou M; Zhang W; Lv L; Chen J; Li L; Wang L; Han X J Cell Mol Med; 2020 Sep; 24(18):10648-10662. PubMed ID: 32725802 [TBL] [Abstract][Full Text] [Related]
13. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer. Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer. Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I. Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653 [TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer. Yong W; Zhuoqi X; Baocheng W; Dongsheng Z; Chuan Z; Yueming S Biomed Pharmacother; 2018 Jun; 102():1188-1194. PubMed ID: 29710537 [TBL] [Abstract][Full Text] [Related]
17. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion. Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234 [TBL] [Abstract][Full Text] [Related]
18. Long intergenic noncoding RNA 00673 promotes non-small-cell lung cancer metastasis by binding with EZH2 and causing epigenetic silencing of HOXA5. Ma C; Wu G; Zhu Q; Liu H; Yao Y; Yuan D; Liu Y; Lv T; Song Y Oncotarget; 2017 May; 8(20):32696-32705. PubMed ID: 28423732 [TBL] [Abstract][Full Text] [Related]
19. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma. Huang B; Huang M; Li Q Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685 [TBL] [Abstract][Full Text] [Related]
20. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]